Similar outcome of calreticulin type I and calreticulin type II mutations following RIC allogeneic haematopoietic stem cell transplantation for myelofibrosis

被引：8
|
作者：
Christopeit, M. [1 ]
Badbaran, A. [1 ]
Zabelina, T. [1 ]
Zeck, G. [1 ]
Fehse, B. [1 ]
Ayuk, F. [1 ]
Wolschke, C. [1 ]
Kroeger, N. [1 ]
机构：
[1] Univ Med Ctr Hamburg, Dept Stem Cell Transplantat, Hamburg, Germany
来源：
BONE MARROW TRANSPLANTATION | 2016年 / 51卷 / 10期
关键词：
MYELOPROLIFERATIVE NEOPLASMS; COMPETING RISK; PROGNOSTIC IMPACT; CALR MUTATIONS; JAK2; CLINICIAN; 1-LIKE; GUIDE; MPL;
D O I：
10.1038/bmt.2016.128
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1391 / 1393
页数：3
相关论文
共 50 条
  • [1] Similar outcome of calreticulin type I and calreticulin type II mutations following RIC allogeneic haematopoietic stem cell transplantation for myelofibrosis
    M Christopeit
    A Badbaran
    T Zabelina
    G Zeck
    B Fehse
    F Ayuk
    C Wolschke
    N Kröger
    Bone Marrow Transplantation, 2016, 51 : 1391 - 1393
  • [2] Similar outcome of calreticulin type I and calreticulin type II mutations following RIC allogeneic hematopoietic stem cell transplantation for myelofibrosis
    Christopeit, M.
    Badbaran, A.
    Zabelina, T.
    Zeck, G.
    Ayuk, F.
    Wolschke, C.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S496 - S496
  • [3] Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation
    Panagiota, V.
    Thol, F.
    Markus, B.
    Fehse, B.
    Alchalby, H.
    Badbaran, A.
    Lehmannt, U.
    Koenecke, C.
    Shahswar, R.
    Chaturvedi, A.
    Stadler, M.
    Eder, M.
    Goehring, G.
    Koenigsmann, M.
    Kloos, A.
    Trummer, A.
    Schroeder, T.
    Kobbe, G.
    Thiede, C.
    Platzbecker, U.
    Schlegelbergers, B.
    Kreipe, H-H
    Ganser, A.
    Kroeger, N.
    Heuser, M.
    LEUKEMIA, 2014, 28 (07) : 1552 - 1555
  • [4] Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation
    V Panagiota
    F Thol
    B Markus
    B Fehse
    H Alchalby
    A Badbaran
    U Lehmann
    C Koenecke
    R Shahswar
    A Chaturvedi
    M Stadler
    M Eder
    G Göhring
    M Koenigsmann
    A Kloos
    A Trummer
    T Schroeder
    G Kobbe
    C Thiede
    U Platzbecker
    B Schlegelberger
    H-H Kreipe
    A Ganser
    N Kröger
    M Heuser
    Leukemia, 2014, 28 : 1552 - 1555
  • [5] Monitoring of Calreticulin mutations and hematopoietic chimerism by digital PCR after allogeneic stem cell transplantation in patients with myelofibrosis
    Badbaran, A.
    Fehse, B.
    Abd Kadi, S. S. S.
    Christopeit, M.
    Aranyossy, T.
    Ayuk, F.
    Wolschke, C.
    Kroeger, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 141 - 142
  • [6] The Prognostic Advantage of Calreticulin Mutations in Myelofibrosis Might be Confined to Type 1 or "type 1-like" Calreticulin Variants
    Tefferi, Ayalew
    Lasho, Terra L.
    Tischer, Alexander
    Wassie, Emnet A.
    Finke, Christy
    Belachew, Alem A.
    Ketterling, Rhett
    Hanson, Curtis A.
    Pardanani, Animesh
    BLOOD, 2014, 124 (21)
  • [7] Digital-PCR assay for screening and quantitative monitoring of calreticulin (CALR) type-2 positive patients with myelofibrosis following allogeneic stem cell transplantation
    Badbaran, A.
    Fehse, B.
    Christopeit, M.
    Aranyossy, T.
    Ayuk, F. A.
    Wolschke, C.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2016, 51 (06) : 872 - 873
  • [8] Digital-PCR assay for screening and quantitative monitoring of calreticulin (CALR) type-2 positive patients with myelofibrosis following allogeneic stem cell transplantation
    A Badbaran
    B Fehse
    M Christopeit
    T Aranyossy
    F A Ayuk
    C Wolschke
    N Kröger
    Bone Marrow Transplantation, 2016, 51 : 872 - 873
  • [9] Development of a Digital-PCR Assay for Screening and Quantitative Monitoring of Calreticulin (CALR) Type-2 Positive Patients with Myelofibrosis Following Allogeneic Stem Cell Transplantation
    Fehse, Boris
    Badbaran, Anita
    Christopeit, Maximilian
    Aranyossy, Tim
    Ayuk, Francis
    Wolschke, Christine
    Kroeger, Nicolaus
    BLOOD, 2015, 126 (23)
  • [10] Screening and Quantitative Monitoring of Calreticulin (CALR) Type-2 Positive Patients with Myelofibrosis Following Allogeneic Stem Cell Transplantation using a novel Digital-PCR Assay
    Kroeger, N.
    Badbaran, A.
    Christopeit, M.
    Wolschke, C.
    Ayuk, F.
    Aranyossy, T.
    Fehse, B.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S85 - S86
12345